ARCH:TSXV ACHFF:OTC
  • Home
  • About usOur story, our approach
  • Our Science Pipeline, research & publications
    • Our Key Platforms
      • MetaBlok™Treating, organ injury caused by inflammation
      • AB569Treatment for Respiratory Pseudomonas aeruginosa Infections
      • BORGPeptide Solid Surface Interface
      • MetaMx™Brain Tumor Initiating Cell Targeting
    • Our PublicationsPeer-reviewed scientific publications
      • AB569
      • Brain Tumor Stem Cell Targeting
      • BORG Peptide Solid Surface Interface
      • Treatments for Inflammation
  • Our Team Management & lead scientists
    • Our ManagementGovernance, Executive, Board of Directors and Advisors
    • Our Principal ScientistsLearn about the scientists behind our technologies
      • MetaBlok™ and MetaMx™
      • AB569 & Respiratory Pseudomonas
      • BORG Peptide
      • Treatments for Inflammation
  • Investor Hub Investor relations, fundamentals
    • Fundamentals
      • Press Releases
      • Investor Information
      • Stock Performance
    • Reports and Filings
      • Management Discussion and Analysis
      • Annual and Quarterly Reports
      • Proxies and Information Circulars
      • Material Change Documents
      • Other SEDAR Filings
  • Contact Us

Proxies and Information Circulars

 

Proxies and Information Circulars 2020
  • Download PDF Documents
    Notice of Meeting and Management Information Circular
    Form of Proxy
    Voter Information Form
    Notice and Access - Beneficial Notice
Proxies and Information Circulars 2019
  • Download PDF Documents
    Notice of Meeting and Management Information Circular
    Form of Proxy
    Confirmation of Mailing
Proxies and Information Circulars 2018
  • Download PDF Documents
    Form of Proxy 2018-03-07
    Voting Instruction Form 2018-03-07
    Notice of Meeting 2018-03-07
Proxies and Information Circulars 2017
  • Download PDF Documents
    Notice of Meeting 2017-03-07
    Form of Proxy 2017-03-07
    Management Information Circular 2017-03-07
    Voting Instruction Form 2017-03-07
Proxies and Information Circulars 2016
  • Download PDF Documents
    Notice of Record and Meeting Dates 2016-02-01
    Form of Proxy 2016-03-30
    Management Information Circular 2016-03-30
Proxies and Information Circulars 2015
  • Download PDF Documents
    Form of Proxy 2015-03-09
    Management Information Circular 2015-03-09
    Notice of Meeting 2015-03-09
Proxies and Information Circulars 2014
  • Download PDF Documents
    Management Information Circular 2014-03-05
Proxies and Information Circulars 2013
  • Download PDF Documents
    Management Information Circular 2013-03-08
Proxies and Information Circulars 2012
  • Download PDF Documents
    Management Information Circular 2013-03-08

Recent News

February 2nd 2021

Arch Biopartners Receives Ethics Committee Approval in Turkey to Dose Additional Patients in the Phase II Trial for LSALT Peptide

Read More
January 5th 2021

University of Calgary Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients

Read More
Arch Biopartners
  • Home
  • About us
  • Our Science
    • Our Key Platforms
    • Our Publications
  • Our Team
    • Our Management
    • Our Principal Scientists
  • Investor Hub
    • Fundamentals
    • Reports and Filings
  • Contact Us
Contact us
+1 647 428 7031
info@archbiopartners.com
Mailing Address
27 St. Clair Ave East
P.O. Box 305
Toronto, Ontario
Canada M4T 2M5
Copyright Arch BioPartners 2020. All Rights Reserved. Legal notices.
PAGE TOP | TYPE SIZE | | RESET
Proxies and Information Circulars
  • Home
  • About us
  • Our Science
    • Our Key Platforms
      • MetaBlok™
      • AB569
      • BORG
      • MetaMx™
    • Our Publications
      • AB569
      • Brain Tumor Stem Cell Targeting
      • BORG Peptide Solid Surface Interface
      • Treatments for Inflammation
  • Our Team
    • Our Management
    • Our Principal Scientists
      • MetaBlok™ and MetaMx™
      • AB569 & Respiratory Pseudomonas
      • BORG Peptide
      • Treatments for Inflammation
  • Investor Hub
    • Fundamentals
      • Press Releases
      • Investor Information
      • Stock Performance
    • Reports and Filings
      • Management Discussion and Analysis
      • Annual and Quarterly Reports
      • Proxies and Information Circulars
      • Material Change Documents
      • Other SEDAR Filings
  • Contact Us